Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Republic of Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore.
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Republic of Singapore.
Ophthalmology. 2021 Oct;128(10):1393-1404. doi: 10.1016/j.ophtha.2021.04.009. Epub 2021 Apr 16.
Glaucoma is the leading cause of irreversible blindness, despite having good prognosis with early treatment. We evaluated the global extent of undetected glaucoma and the factors associated with it in this systematic review and meta-analysis.
Undetected glaucoma increases the risk of vision impairment, which leads to detrimental effects on the quality-of-life and socioeconomic well-being of those affected. Detailed information on the extent and factors associated with undetected glaucoma aid in the development of public health interventions.
We conducted a systematic review and meta-analysis of population-based studies published between January 1, 1990, and June 1, 2020. Article search was conducted in online databases (PubMED, Web-of-Science), grey literatures (OpenGrey), and nongovernment organization reports. Our outcome measure was the proportion of glaucoma cases that were undetected previously. Manifest glaucoma included any form of glaucoma reported in the original studies and may include primary open-angle glaucoma (POAG), primary angle-closure-glaucoma, secondary glaucoma, or a combination thereof. Undetected glaucoma was defined as glaucoma cases that were undetected prior to diagnosis in the respective study. Random-effect meta-analysis was used to estimate the pooled proportion of undetected glaucoma. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and the Meta-analysis of Observational Studies in Epidemiology guidelines in our study.
We identified 61 articles from 55 population-based studies (n = 189 359 participants; n = 6949 manifest glaucoma). Globally, more than half of all glaucoma cases were undetected previously on average in each geographical region. Africa (odds ratio [OR], 12.70; 95% confidence interval [CI], 4.91-32.86) and Asia (OR, 3.41; 95% CI, 1.63-7.16) showed higher odds of undetected glaucoma as compared with Europe. Countries with low Human Development Index (HDI; <0.55) showed a higher proportion of undetected manifest glaucoma as compared with countries of medium to very high HDI (≥0.55; all P < 0.001). In 2020, 43.78 million POAG cases were projected to be undetected, of which 76.7% were in Africa and Asia.
Undetected glaucoma is highly prevalent across diverse communities worldwide and more common in Africa and Asia. Strategies to improve detection are needed to prevent excess visual disability and blindness resulting from glaucoma.
尽管早期治疗可获得良好的预后,但青光眼仍是导致不可逆性失明的主要原因。本系统评价和荟萃分析评估了全球范围内未被发现的青光眼的程度及其相关因素。
未被发现的青光眼会增加视力受损的风险,从而对受影响人群的生活质量和社会经济福利产生不利影响。详细了解未被发现的青光眼的程度和相关因素有助于制定公共卫生干预措施。
我们对 1990 年 1 月 1 日至 2020 年 6 月 1 日期间发表的基于人群的研究进行了系统评价和荟萃分析。文章检索在在线数据库(PubMed、Web-of-Science)、灰色文献(OpenGrey)和非政府组织报告中进行。我们的结局测量是先前未被发现的青光眼病例比例。显性青光眼包括原始研究报告的任何形式的青光眼,可能包括原发性开角型青光眼(POAG)、原发性闭角型青光眼、继发性青光眼或其组合。未被发现的青光眼定义为在各自研究中诊断前未被发现的青光眼病例。使用随机效应荟萃分析估计未被发现的青光眼的合并比例。我们在研究中遵循了系统评价和荟萃分析的首选报告项目以及观察性研究荟萃分析的指南。
我们从 55 项基于人群的研究中确定了 61 篇文章(n=189359 名参与者;n=6949 例显性青光眼)。全球范围内,各地区平均有超过一半的青光眼病例之前未被发现。与欧洲相比,非洲(比值比[OR],12.70;95%置信区间[CI],4.91-32.86)和亚洲(OR,3.41;95%CI,1.63-7.16)的未被发现的青光眼病例的可能性更高。人类发展指数(HDI)较低的国家(<0.55)与中等到极高 HDI(≥0.55)的国家相比,显性青光眼的未被发现比例更高(均 P<0.001)。2020 年,预计将有 4378 万例 POAG 病例未被发现,其中 76.7%在非洲和亚洲。
在全球范围内,不同社区中未被发现的青光眼患病率很高,在非洲和亚洲更为常见。需要采取策略来提高检测率,以防止因青光眼导致的过度视力残疾和失明。